BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shakoori Z, Ghanbari H, Omidi Y, Pashaiasl M, Akbarzadeh A, Jomeh Farsangi Z, Rezayat SM, Davaran S. Fluorescent multi-responsive cross-linked P(N-isopropylacrylamide)-based nanocomposites for cisplatin delivery. Drug Development and Industrial Pharmacy 2017;43:1283-91. [DOI: 10.1080/03639045.2017.1313859] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Abedi F, Ghandforoushan P, Adeli F, Yousefnezhad M, Mohammadi A, Moghaddam S, Davaran S. Development of stimuli-responsive nanogels as drug carriers and their biomedical application in 3D printing. Materials Today Chemistry 2023;29:101372. [DOI: 10.1016/j.mtchem.2022.101372] [Reference Citation Analysis]
2 Shrivastava P, Vishwakarma N, Gautam L, Vyas SP. Magnetically responsive polymeric gels and elastomeric system(s) for drug delivery. Smart Polymeric Nano-Constructs in Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91248-8.00012-x] [Reference Citation Analysis]
3 Ali AA, Al-Othman A, Al-Sayah M. Multifunctional stimuli-responsive hybrid nanogels for cancer therapy: Current status and challenges. J Control Release 2022:S0168-3659(22)00628-9. [PMID: 36170926 DOI: 10.1016/j.jconrel.2022.09.033] [Reference Citation Analysis]
4 Shakoori Z, Pashaei-asl R, Pashaiasl M, Davaran S, Ghanbari H, Ebrahimie E, Rezayat SM. Biocompatibility study of P (N-isopropylacrylamide)-based nanocomposite and its cytotoxic effect on HeLa cells as a drug delivery system for Cisplatin. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103254] [Reference Citation Analysis]
5 Omidi Y, Omidian H, Kwon Y, Castejon A. Blood–brain barrier and nanovesicles for brain-targeting drug delivery. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00007-9] [Reference Citation Analysis]
6 Sahu BP, Biswas N, Das MK. Multifunctional nanotheranostics for cancer diagnosis and treatments. Multifunctional Theranostic Nanomedicines in Cancer 2021. [DOI: 10.1016/b978-0-12-821712-2.00008-6] [Reference Citation Analysis]
7 Fathi M, Abdollahinia ED, Amiryaghoubi N, Omidian H, Omidi Y. Magnetic nanoparticle-polymer nanohybrids. Magnetic Nanoparticle-Based Hybrid Materials 2021. [DOI: 10.1016/b978-0-12-823688-8.00009-0] [Reference Citation Analysis]
8 Sung B, Kim MH, Abelmann L. Magnetic microgels and nanogels: Physical mechanisms and biomedical applications. Bioeng Transl Med 2021;6:e10190. [PMID: 33532590 DOI: 10.1002/btm2.10190] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
9 Ghaeini-Hesaroeiye S, Razmi Bagtash H, Boddohi S, Vasheghani-Farahani E, Jabbari E. Thermoresponsive Nanogels Based on Different Polymeric Moieties for Biomedical Applications. Gels 2020;6:E20. [PMID: 32635573 DOI: 10.3390/gels6030020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
10 Sahu BP, Biswas N, Das MK. Multifunctional Nanoscale Particles for Theranostic Application in Healthcare. Nano Medicine and Nano Safety 2020. [DOI: 10.1007/978-981-15-6255-6_14] [Reference Citation Analysis]
11 Fathi M, Safary A, Barar J. Therapeutic impacts of enzyme-responsive smart nanobiosystems. Bioimpacts 2020;10:1-4. [PMID: 31988850 DOI: 10.15171/bi.2020.01] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
12 Safary A, Akbarzadeh Khiavi M, Omidi Y, Rafi MA. Targeted enzyme delivery systems in lysosomal disorders: an innovative form of therapy for mucopolysaccharidosis. Cell Mol Life Sci 2019;76:3363-81. [DOI: 10.1007/s00018-019-03135-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
13 Lee W, Kim D, Lee S, Park J, Oh S, Kim G, Lim J, Kim J. Stimuli-responsive switchable organic-inorganic nanocomposite materials. Nano Today 2018;23:97-123. [DOI: 10.1016/j.nantod.2018.10.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
14 Aghanejad A, Babamiri H, Adibkia K, Barar J, Omidi Y. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells. Bioimpacts 2018;8:117-27. [PMID: 29977833 DOI: 10.15171/bi.2018.14] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
15 Kumar S, Sarita, Nehra M, Dilbaghi N, Tankeshwar K, Kim K. Recent advances and remaining challenges for polymeric nanocomposites in healthcare applications. Progress in Polymer Science 2018;80:1-38. [DOI: 10.1016/j.progpolymsci.2018.03.001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 20.8] [Reference Citation Analysis]
16 Farshbaf M, Salehi R, Annabi N, Khalilov R, Akbarzadeh A, Davaran S. pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imaging. Drug Development and Industrial Pharmacy 2018;44:452-62. [DOI: 10.1080/03639045.2017.1397686] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
17 Asgharzadeh MR, Barar J, Pourseif MM, Eskandani M, Jafari Niya M, Mashayekhi MR, Omidi Y. Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy. Bioimpacts 2017;7:115-33. [PMID: 28752076 DOI: 10.15171/bi.2017.15] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 11.7] [Reference Citation Analysis]